ORIC (ORIC Pharmaceuticals Inc) Earnings per share for the last four quarters

Public company logo of ORIC Pharmaceuticals Inc (ORIC)

ORIC Pharmaceuticals faces dependency on clinical trial outcomes and fierce competition within targeted therapy. Meanwhile, medical professionals value the company for its scientific approach to overcoming tumor resistance. This rolling year-over-year EPS chart illustrates profit dynamics, where the metric level stands at 29.20. The implementation of robotic molecule screening could significantly accelerate the development of new drugs.

ORIC oricpharma.com Earnings per share for the last twelve months (02/11/2024 - 11/12/2026)

ORIC Pharma - analytical breakdowns and key metrics (ORIC)

- current price and projected stock value:
Price Performance Chart oricpharma.com|ORIC - Consensus Target
- business market valuation indicators:
Market Value ORIC Pharmaceuticals Inc|ORIC - Enterprise Value
- business book valuation details:
Book Value per Share ORIC Pharmaceuticals|ORIC - Company Book Value|Market Value to Book Value oricpharma.com|ORIC - Company Total Assets
- company total debt and liquidity indicators:
Debt to Capital Ratio ORIC Pharmaceuticals|ORIC - Long-Term Debt to Capital|Current Liabilities to Capital ORIC Corp|ORIC - Company Total Debt|Debt to Book Capital ORIC Pharmaceuticals Inc|ORIC - Company Long-Term Debts|Short-Term Debt ORIC Pharmaceuticals|Immediate Liquidity Ratio oricpharma.com
- earnings and multiples data:
ORIC - Net Income|Expected Net Income ORIC Pharmaceuticals|ORIC - Price to Earnings Ratio|Market Cap to Future Earnings Ratio ORIC Pharmaceuticals Inc|ORIC - PEG Multiple|Business Value to Operating Income Before Depreciation ORIC Pharmaceuticals Inc|ORIC - Operating profit EBITDA|Net earnings per one share for the last twelve months ORIC Pharmaceuticals|ORIC - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months oricpharma.com|ORIC - Earnings growth in current year|Earnings growth forecast for next year ORIC Pharmaceuticals
Fundamental valuation:oricpharma.com (ORIC)
Signature product of ORIC Pharmaceuticals, Inc.

For ORIC Pharmaceuticals, whose viability depends on the success of clinical trials for targeted drugs, this indicator reflects the efficiency of monetizing R&D assets. By analyzing the annual change in net income per share over a rolling period, an investor can see the difference between the current and previous TTM EPS value, allowing for an assessment of the company's financial stability amidst fierce competition and underfunding risks.

Competitor analysis for ORIC Pharmaceuticals

Earnings per share for the trailing year GMAB (genmab.com)|EXEL (Exelixis) - Net earnings per share for the last 12 months|NUVL: Earnings per share for the last four quarters|KYMR (Kymera Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) IDEAYA Corp|Earnings per share for the last twelve months Enliven Therapeutics (ELVN)|RLAY (relaytx.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) NRIX (Nurix Therapeutics, Inc.)|Net earnings per share for the trailing year Tyra Biosciences Inc|Verastem Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Monte Rosa Corp|CGEM (Cullinan Therapeutics) - Net earnings per share for the last 12 months|IMRX: Earnings per share for the last four quarters|CCCC (C4 Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Black Diamond Therapeutics, Inc. BDTX|Net earnings per share (EPS TTM) RPTX|PMV Pharmaceuticals, Inc - Earnings per share for the last 12 months|Karyopharm Therapeutics Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year PPCB|BGMS: Net earnings per share for the last 12 months|Aadi Bioscience - Earnings per share for the last four quarters|ALRN: Net earnings per share (EPS TTM)|Blueprint Medicines Corporation - Earnings per share for the trailing year|GLYC (GlycoMimetics Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months springworkstx.com SWTX